Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
Ana E. Espinosa De Ycaza, Juan P. Brito, Rozalina G. McCoy, et al.
Thyroid (2024)
Closed Access | Times Cited: 16

Showing 16 citing articles:

Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials
Yuming Sun, Yongjia Liu, Yating Dian, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 13
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group
Andrej Janež, Emir Muzurović, Paweł Bogdański, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 9, pp. 1865-1892
Open Access | Times Cited: 11
GLP-1RA Use and Thyroid Cancer Risk
Juan P. Brito, Jeph Herrin, Kavya Swarna, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access | Times Cited: 1
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels
Stefania Capuccio, Sabrina Scilletta, Francesca La Rocca, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 687-687
Open Access | Times Cited: 6
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Irene Caruso, Ludovico Di Gioia, Sergio Di Molfetta, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 11, pp. 2671-2678
Open Access | Times Cited: 4
Increased Incidence or Detection Bias? Global Cohort Study Finds No Link between GLP1-RAs and Thyroid Cancer Risk
Omar El Kawkgi
Clinical Thyroidology (2025) Vol. 37, Iss. 1, pp. 33-36
Closed Access
Current and new treatment options for adults recently diagnosed with type 2 diabetes
Tamara K. Oser, Catherine Varney, Anthony L. McCall, et al.
Family Medicine and Community Health (2025) Vol. 13, Iss. 1, pp. e003154-e003154
Open Access
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence
Anqi Lin, Yanxi Ding, Zhengrui Li, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists
Clare A. Kelly, Jennifer A. Sipos
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 3
Environmental factors related to the origin and evolution of differentiated thyroid cancer: a narrative review
José Paz‐Ibarra, Marcio José Concepción‐Zavaleta, Juan Eduardo Quiroz‐Aldave
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 6, pp. 469-477
Closed Access | Times Cited: 2
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment
Mansour Tobaiqy
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 981-990
Closed Access | Times Cited: 2
Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
Yu‐Nan Huang, Wen‐Ling Liao, Jing‐Yang Huang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 5222-5232
Closed Access | Times Cited: 2
A Review of Thyroid Cancer—Reply
Laura Boucai, Mark Zafereo, Maria E. Cabanillas
JAMA (2024) Vol. 331, Iss. 21, pp. 1863-1863
Closed Access | Times Cited: 1
Pharmacotherapy of obesity: State of the art and perspectives
Katarina Sićović, Ana Micov
Arhiv za farmaciju (2024) Vol. 74, Iss. 3, pp. 460-482
Open Access | Times Cited: 1
Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
André Lacroix, Isabelle Bourdeau, Fanny Chasseloup, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 11, pp. 837-855
Closed Access
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
Page 1

Scroll to top